Innate Pharma SA
PAR:IPH
Innate Pharma SA
PAR:IPH
Price:
1.71
EUR
0.59%
Market Cap:
€160.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Innate Pharma SA
PAR:IPH
|
FR |
|
A
|
AustAsia Group Ltd
HKEX:2425
|
CN |
|
W
|
WatosCorea Co Ltd
KOSDAQ:079000
|
KR |
|
R
|
Realogy Holdings Corp
F:04M
|
US |
|
Shenyang Commercial City Co Ltd
SSE:600306
|
CN |
|
I
|
Ithaca Energy PLC
LSE:ITH
|
UK |
|
Moneta Gold Inc
TSX:ME
|
CA |
|
Protector Forsikring ASA
OTC:PSKRF
|
NO |
|
P
|
Polaris Bay Group Co Ltd
SSE:600155
|
CN |
|
C
|
Charles Schwab Corp
F:SWG
|
US |
|
N
|
Norsk Hydro ASA
XMUN:NOH1
|
NO |
|
Kunlun Energy Company Ltd
HKEX:135
|
HK |
Multiples-Based Value
The Multiples-Based Value for Innate Pharma SA (IPH) under the Base Case is hidden
EUR.
Compared with the current market price of 1.71 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IPH Multiples-Based Value
LOCKED
